180 Degree Capital Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 3/6

180 Degree Capital şirketinin toplam hissedar öz sermayesi $45.0M ve toplam borcu $0.0 olup, bu da borç-öz sermaye oranını 0% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla $46.0M ve $934.4K dir.

Anahtar bilgiler

Borç/özkaynak oranı

US$0

Borç

Faiz karşılama oranı	n/a
Nakit	US$282.17k
Eşitlik	US$45.04m
Toplam yükümlülükler	US$934.36k
Toplam varlıklar	US$45.98m

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: HH20 'nin kısa vadeli varlıkları ( $412.9K ) kısa vadeli yükümlülüklerini ( $305.2K ) aşıyor.

Uzun Vadeli Yükümlülükler: HH20 'un kısa vadeli varlıkları ( $412.9K ) uzun vadeli yükümlülüklerini ( $629.1K ) karşılamamaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: HH20 borçsuzdur.

Borcun Azaltılması: HH20 un 5 yıl önce borcu yoktu.

Bilanço

Nakit Pist Analizi

Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.

İstikrarlı Nakit Pisti: HH20 şirketinin mevcut serbest nakit akışına göre bir yıldan az nakit akışı süresi bulunmaktadır.

Tahmini Nakit Akışı: HH20 un, serbest nakit akışı her yıl % 34.9 oranında tarihi oranda azalmaya devam ederse bir yıldan az nakit akışı süresi vardır

180 Degree Capital Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 3/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Recent updates

First half 2024 earnings released: US$0.52 loss per share (vs US$0.16 loss in 1H 2023)

New major risk - Financial position

180 Degree Capital Corp. to Report Q2, 2024 Results on Aug 19, 2024

Chairman recently bought €54k worth of stock

Chairman recently bought €74k worth of stock

180 Degree Capital Corp. to Report Q1, 2024 Results on May 13, 2024

180 Degree Capital Corp., Annual General Meeting, Apr 15, 2024

180 Degree Capital Corp. to Report Q4, 2023 Results on Feb 20, 2024

180 Degree Capital Corp. to Report Q3, 2023 Results on Nov 13, 2023

Insufficient new directors

VP & Head of Fund Development recently bought €162k worth of stock

Chairman recently bought €200k worth of stock

Chairman recently bought €105k worth of stock

Chairman recently bought €51k worth of stock

Chairman recently bought €51k worth of stock

VP & Head of Fund Development recently bought €255k worth of stock

180 Degree Capital Corp. to Report Q3, 2022 Results on Nov 07, 2022

Chairman recently bought €60k worth of stock

180 Degree Capital Corp. to Report Q2, 2022 Results on Aug 08, 2022

180 Degree Capital Corp. to Report Q1, 2022 Results on May 11, 2022

Valo Health, Inc. acquired TARA Biosystems, Inc. from 180 Degree Capital Corp. (NasdaqGM:TURN), Alexandria Venture Investments, LLC, Mérieux Equity Partners SAS, LifeForce Capital, DEFTA Partners, New York City Investment Fund Manager, Inc. and others.

180 Degree Capital Corp., Annual General Meeting, Apr 20, 2022

Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat

180 Degree Capital Corp. to Report Q4, 2021 Results on Feb 24, 2022

Chairman recently bought €75k worth of stock

Chairman recently bought €57k worth of stock

Chairman recently bought €57k worth of stock

Chairman recently bought €128k worth of stock

First half 2021 earnings released: EPS US$1.40 (vs US$1.09 loss in 1H 2020)

Chairman recently bought €57k worth of stock

Zymergen Inc. (NasdaqGS:ZY) acquired Lodo Therapeutics Corp. from Accelerator Life Science Partners I, managed by Accelerator Life Science Partners and others.

Chairman recently bought €121k worth of stock

180 Degree Capital Corp., Annual General Meeting, Apr 20, 2021

Full year 2020 earnings released

180 Degree Capital Corp. to Report Q4, 2020 Results on Feb 22, 2021

New 90-day high: €5.65

Chairman recently bought €123k worth of stock

New 90-day high: €1.75

180 Degree Capital Corp. to Report Q3, 2020 Results on Nov 18, 2020

New 90-day low: €1.43

Synacor, Inc. (NasdaqGM:SYNC) entered into a merger agreement to acquire Qumu Corporation (NasdaqCM:QUMU) from 180 Degree Capital Corp. (NasdaqGM:TURN), Harbert Discovery Fund, LP, managed by Harbert Fund Advisors Inc. and others for $33.5 million in a merger of equals transaction.

New 90-day high - €1.69

An unknown buyer acquired Petra Pharma Corporation from 180 Degree Capital Corp. (NasdaqGM:TURN).

180 Degree Capital Corp. to Report Q2, 2020 Results on Aug 10, 2020

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Nakit Pist Analizi

Sağlıklı şirketleri keşfedin